Wang J et al. indicated that B3GNT3 may promote the growth, invasion and migration of endometrial cancer cells by regulating markers related to the RhoA/RAC1 signaling pathway, suggesting that B3GNT3 may be a candidate biomarker for EC therapeutic intervention23. Here, B3GNT3 is linked to endometrial cancer.